Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5P62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,988
Award facts
- Contract value 100% obligated
- $11,987.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pens totaling $11,987.86 on November 25, 2025, with completion targeted for November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent is a biologic medication indicated for multiple conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, making it relevant to military and veteran healthcare systems served through the DLA Medical Supply Chain. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor supplying specialized medications and medical supplies across diverse therapeutic domains. The company's comprehensive IDC vehicle enables flexible procurement of pharmaceutical products to support military healthcare programs globally, with the DLA planning to establish additional regional pharmaceutical prime vendor contracts involving multiple contractors for future generations of this program.
Quick answers
Who was awarded contract SPE2DR26F5P62?
SPE2DR26F5P62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F5P62 worth?
The government has obligated $11,988 on SPE2DR26F5P62.
Is contract SPE2DR26F5P62 an order under another contract?
Yes. SPE2DR26F5P62 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5P62 competed?
The extent of competition for SPE2DR26F5P62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award